血清25羟基维生素D<sub>3</sub>联合骨代谢指标检测在老年骨质疏松症筛查中的应用价值

doi:10.3969/j.issn.1671-7171.2023.11.024

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1204 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the application value of serum 25-hydroxyvitamin D₃ combined with bone metabolism index in the screening of elderly osteoporosis. 【Methods】A total of 96 elderly osteoporosis patients admitted to our hospital from July 2020 to July 2022 were selected as the observation group,and 96 healthy elderly people who underwent physical examination during the same period were selected as the control group. Patients in both groups underwent lumbar spine bone density,femoral neck bone density measurements,as well as measurements of serum 25-hydroxyvitamin D₃ [25-(OH)D₃],bone metabolism indices (N-MID,P1NP,β-CTX),and inflammatory factors (TNF-α,IL-6). The test results of the two groups were compared. 【Results】The lumbar spine bone density and femoral neck bone density of the observation group were significantly lower than those of the control group,while levels of N-MID,P1NP and β-CTX in the observation group were higher than those in the control group. The serum 25-(OH)D₃ level in the observation group was lower than that in the control group,and levels of inflammatory factors TNF-α and IL-6 in the observation group were significantly higher than those in the control group. The differences were statistically significant(P<0.05). 【Conclusion】The detection of serum 25-(OH)D₃ combined with bone metabolism index in the screening of elderly osteoporosis can significantly improve the screening effect and early detection rate,help to assess the patient's condition and quality of life,and has important clinical application value.

Key words： Osteoporosis/TH Hydroxycholecalciferols/BL Bone and Bones/ME Aged

Received: 12 September 2023

PACS:

R68

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LU Jie
	LI Qian
	LIU Na

Cite this article:

LU Jie,LI Qian,LIU Na. Application of Serum 25-Hydroxyvitamin D₃ Combined with Bone Metabolism Indicators in the Screening of Osteoporosis in the Elderly[J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(11): 1697-1699.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.11.024 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I11/1697

[1] 岳斌,张巍,徐丽,等. 老年2型糖尿病合并骨质疏松患者骨密度变化与血清激素水平、骨代谢指标及血脂的关系[J].海南医学,2023,34(2):185-189.
[2] 王欣燕,刘建红,黄显元. 青娥丸对绝经后骨质疏松症患者骨密度、骨代谢指标和骨硬化蛋白的影响[J].中国骨质疏松杂志,2020,26(3):412-415.
[3] 郝泽普,武晔,王晓磊,等. 坚骨胶囊联合阿仑膦酸钠对老年骨质疏松患者骨密度及血清酪氨酸3-单加氧酶/色氨酸5-单加氧酶激活蛋白eta、炎症指标的影响[J].分子影像学杂志,2023,46(1):98-102.
[4] 钱一飞,王颖,王旭. 血塞通片联合特立帕肽治疗老年骨质疏松症的临床研究[J].药物评价研究,2020,43(7):1347-1350.
[5] 《中国老年骨质疏松症诊疗指南》(2018)工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等. 中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
[6] 侯江业,刘鹏,陈强,等. 老年原发性骨质疏松患者血清骨代谢指标的变化观察[J].贵州医药,2021,45(11):1761-1762.
[7] 戴文昊,刘亦冰,解强,等. 老年骨质疏松症合并髋部骨折患者外周T淋巴细胞亚群、炎性细胞因子水平与骨代谢生化指标的关系[J].广东医学,2022,43(6):740-744.
[8] 冯红红,高飞. 新型炎症因子与原发性骨质疏松症的研究进展[J].中国骨质疏松杂志,2022,28(1):152-156.
[9] 曾海勇,陈淑娟,李明政,等. 唑来膦酸治疗绝经后骨质疏松疗效及对外周淋巴细胞亚群及骨代谢标记物的影响[J].广东医学,2019,40(12):1759-1762.
[10] 张铎安,党兴,陈兆兴. 唑来膦酸结合钙尔奇对老年脑梗死合并骨质疏松症患者疗效影响的临床研究[J].中国骨质疏松杂志,2017,23(11):1468-1471.
[11] 管玉涛,蔡莲莲,丁红香,等. 不同方案联合用药治疗围绝经期及绝经后期骨质疏松症的疗效观察[J].中华妇产科杂志,2010,45(8):571-574.
[12] 李沁,陈登科. 唑来膦酸联合钙剂治疗老年慢性阻塞性肺疾病患者骨质疏松症的临床疗效[J].中国骨质疏松杂志,2018,24(2):222-225.
[13] 赵敏. 老年骨质疏松症患者25羟基维生素D₃和骨代谢指标水平变化及其与骨密度的相关性分析[J].海军医学杂志,2020,41(6):721-723.
[14] 孔劲松,阮建伟,黄杨,等. 老年骨质疏松症患者骨代谢指标变化、生长分化因子15及其炎症因子水平分析[J].中国卫生检验杂志,2020,30(14):1710-1712.
[15] 马焕芹,赵晶,张恒岩,等. 骨质疏松性椎体压缩骨折患者入院前疼痛时长与经皮椎体后凸成形术后生活质量改善的关系分析[J].中华骨与关节外科杂志,2023,16(4):361-366.